Internal Medicine, Pulmonary Disease · New Smyrna Beach, FL
NPI
1205889243
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1055 N Dixie Fwy, Suite 1
New Smyrna Beach, FL, 32168
Phone (386) 423-0505
Groups this clinician bills Medicare through
Medicare paid, 2024
$997K
59,969 services
Medicare patients, 2024
2,242
Average age 76
Drug cost, 2024
$2.2M
12,643 prescriptions
Company payments, 2025
$2,716
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Theodossis Zacharis was code J1010 (injection, methylprednisolone acetate, 1 mg), 29,929 times for 258 patients. In total Theodossis Zacharis billed 59,969 services in 72 codes, and Medicare paid $997K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-24.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 29,929 | 258 | $0.10 | $3,041 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 11,102 | 187 | $0.09 | $1,002 |
| 99214 Office E&M - Established | Office | 3,837 | 1,399 | $94.88 | $364K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 1,869 | 95 | $0.36 | $678 |
| 94060 Pulmonary Function Testing | Office | 1,613 | 1,100 | $28.41 | $46K |
| 96365 Intravenous Infusion, Hydration | Office | 1,360 | 200 | $46.59 | $63K |
| 99233 Hospital E&M - Subsequent | Facility | 1,340 | 428 | $92.29 | $124K |
| 96375 Injection Administration | Office | 1,268 | 192 | $11.51 | $15K |
| J1956 Injection, levofloxacin, 250 mg | Office | 1,068 | 121 | $0.77 | $827 |
| 94729 Pulmonary Function Testing | Office | 982 | 934 | $41.69 | $41K |
| 94726 Pulmonary Function Testing | Office | 979 | 930 | $40.98 | $40K |
| 96372 Injection Administration | Office | 544 | 336 | $10.67 | $5,804 |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 420 | 34 | $8.94 | $3,756 |
| 99232 Hospital E&M - Subsequent | Facility | 379 | 206 | $61.30 | $23K |
| J0692 Injection, cefepime hydrochloride, 500 mg | Office | 374 | 15 | $0.97 | $361 |
By year: 2022 $839K for 25,126 services; 2023 $978K for 28,670 services; 2024 $997K for 59,969 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 12 | $5.88 | $99.96 |
Medicare prescription drug claims, 2024
In 2024, the drug Theodossis Zacharis prescribed most often to Medicare patients was Montelukast Sodium, with 1,789 prescriptions and refills. In total Theodossis Zacharis wrote 12,643 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,789 | 4,734 | 635 | $29K |
| Prednisone Generic | 1,452 | 1,616 | 626 | $8,728 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 835 | 1,539 | 244 | $939K |
| Doxycycline Hyclate Generic | 789 | 789 | 472 | $8,982 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 740 | 1,089 | 273 | $21K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 643 | 1,254 | 241 | $84K |
| Fluticasone Propionate Generic | 398 | 761 | 160 | $7,041 |
| Azithromycin Generic | 352 | 554 | 111 | $4,367 |
| Levofloxacin Generic | 350 | 350 | 213 | $3,111 |
| Cefdinir Generic | 338 | 338 | 198 | $5,342 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 244 | 338 | 80 | $30K |
| Ipratropium Bromide Generic | 244 | 411 | 121 | $6,282 |
| Furosemide Generic | 217 | 387 | 74 | $1,133 |
| Breo Ellipta Fluticasone/Vilanterol | 189 | 312 | 59 | $117K |
| Fluconazole Generic | 188 | 196 | 105 | $1,545 |
Brand drugs: - claims; generic drugs: 9,760 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Theodossis Zacharis $2,716 ($2,716 in general payments such as food, travel and fees) from 24 companies. The largest payer was GlaxoSmithKline, LLC. with $405.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 25 | $405 |
| Jazz Pharmaceuticals Inc. JAZZ | 9 | $307 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $301 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $240 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $203 |
| Insmed, Inc. INSM | 18 | $201 |
| Pulmonx Corporation LUNG | 3 | $189 |
| Genzyme Corporation SNY | 6 | $150 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $83.15 |
| Amgen Inc. AMGN | 3 | $78.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.